CDX-2 is a marker of gastrointestinal tumors, especially colorectal cancer, while urothelial tumors do not express CDX-2,[12] which can be used to differentiate adenocarcinomas from the gastrointestinal tract. Here, CDX2 is linked to digestive system neoplasm.